GlassScriptPhysician profile
Scott A Lemek
NPI 1952304404
$913.18
in general payments reported to CMS, 2019-2025
15 companies · $127 in 2025
The $127 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $89.57 · 2020: $112 · 2021: $87.76 · 2022: $258 · 2023: $152 · 2024: $86.95 · 2025: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $366.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $365.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $405.53 | 2019-2024 | Axsos, Gamma, Variax |
| Depuy Synthes Sales INC. | $105.17 | 2020-2025 | Va-Lcp |
| Pacira Pharmaceuticals Incorporated | $84.98 | 2019-2025 | Exparel, Zilretta, Iovera |
| Heron Therapeutics, INC. | $49.53 | 2021-2024 | Zynrelef |
| Vertex Pharmaceuticals Incorporated | $46.19 | 2025 | |
| Conetic Solutions, INC. | $39.62 | 2022 | |
| Integra Lifesciences Corporation | $32.68 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Paratek Pharmaceuticals, INC. | $28.16 | 2021 | |
| Kci USA, INC. | $20.92 | 2020 | |
| Vericel Corporation | $18.85 | 2022 | |
| Linvatec Corporation | $17.94 | 2022 | |
| Zimmer Biomet Holdings, INC. | $17.05 | 2025 | Osseofit |
| Rsw Medical Company, INC. | $17.03 | 2019 | |
| Sanara Medtech INC. | $16.60 | 2024 | Celleraterx |
| Smith+Nephew, INC. | $12.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Lemek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.